Literature DB >> 33713236

Expression of Transcription Factor PU.1 in Stromal Cells as a Prognostic Marker in Non-Small Cell Lung Cancer.

O V Kovaleva1, M A Rashidova2, D V Samoilova2, P A Podlesnaya2, V V Mochalnikova2, A N Gratchev2.   

Abstract

Transcription factor PU.1 is involved in hematopoiesis and is expressed in various cells of the inflammatory infiltrate of the tumor stroma, mainly in macrophages. The expression of PU.1 in 100 samples of non-small cell lung cancer was analyzed by the immunohistochemical method. The number of PU.1+ cells did not correlate with clinical and morphological parameters of the tumors. However, increased number of PU.1+ cells significantly correlated with favorable prognosis in adenocarcinoma and poor prognosis in squamous cell carcinoma. Thus, transcription factor PU.1 can serve as a stromal prognostic marker of non-small cell lung cancer depending on the histological type of the tumor.

Entities:  

Keywords:  lung cancer; macrophage; survival; transcription factor PU.1

Year:  2021        PMID: 33713236     DOI: 10.1007/s10517-021-05094-7

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN: 0007-4888            Impact factor:   0.804


  2 in total

Review 1.  Novel prognostic molecular markers in lung cancer.

Authors:  Michał Puderecki; Justyna Szumiło; Barbara Marzec-Kotarska
Journal:  Oncol Lett       Date:  2020-04-15       Impact factor: 2.967

2.  PU.1 and Haematopoietic Cell Fate: Dosage Matters.

Authors:  Ka Sin Mak; Alister P W Funnell; Richard C M Pearson; Merlin Crossley
Journal:  Int J Cell Biol       Date:  2011-08-10
  2 in total
  1 in total

1.  Comprehensive analysis of BTN3A1 in cancers: mining of omics data and validation in patient samples and cellular models.

Authors:  Fan Liang; Chen Zhang; Hua Guo; San-Hui Gao; Fu-Ying Yang; Guang-Biao Zhou; Gui-Zhen Wang
Journal:  FEBS Open Bio       Date:  2021-08-04       Impact factor: 2.693

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.